Digital Health Global

NOVEMBER 12, 2024

23andMe tried to monetize its extensive genetic database by collaborating with pharmaceutical companies for drug research. While promising, drug development requires significant time and investment, delaying any financial returns and impacting the company’s short-term revenue.

Pharmaceuticals 88

Pharmaceuticals BioTech Leadership Drug Development 88

Digital Health Global

JANUARY 10, 2024

LAUSANNE, Switzerland & SAN DIEGO–(BUSINESS WIRE)–Debiopharm, an independent biopharmaceutical company headquartered in Switzerland, and ThinkingNodeLife.ai (TNL), a trailblazer in AI Digital Cells Lab in USA, are pleased to announce a collaborative partnership aimed at advancing the development of a cutting-edge cancer drug.

Drug Development 88

Drug Development Pharmaceuticals Digital Health 88

Digital Health Global

JANUARY 28, 2025

a leading provider of clinical development technology, today announced new data from the Tufts Center for the Study of Drug Development (CSDD)s PACT Consortium links decentralized clinical trial (DCT) approaches to notably higher participation rates across multiple demographic groups. PALO ALTO, Calif.–(BUSINESS

Drug Development 88

Drug Development Pharmaceuticals Digital Health 88

Digital Health Global

MARCH 29, 2023

With ResponderID, we sought to disrupt the historical linear progression of drug discovery and development, rather aiming to close the loop between drug development, patient care and new drug discovery,” said Rafael Rosengarten, Ph.D., co-founder and CEO of Genialis. “We

Drug Development 128

Drug Development Pharmaceuticals Life Science Digital Health 128

Healthcare IT News - Telehealth

MAY 29, 2020

“These technologies can also be leveraged by pharmaceutical companies to monitor the results of the drugs developed by them," said Ashish Kaul, technical insights senior research analyst at Frost & Sullivan. THE LARGER CONTEXT.

Mental health 180

Mental health Drug Development Pharmaceuticals Telehealth 180

Digital Health Global

JANUARY 29, 2025

a leading provider of clinical development technology, today announced new data from the Tufts Center for the Study of Drug Development (CSDD)s PACT Consortium linking decentralized clinical trial (DCT) approaches to notably higher proportional representation among select demographic subgroups. Medable Inc.,

Drug Development 88

Drug Development Pharmaceuticals Digital Health 88

Lloyd Price

NOVEMBER 16, 2024

Watson for Drug Discovery: This product is used by pharmaceutical companies to identify new drug targets and develop new treatments. These challenges include: High costs: Watson is expensive to develop and maintain. Clinical Development: Clinical Trial Matching: Matches patients to appropriate clinical trials.

Drug Development 68

Drug Development healthcare technology Leadership Life Science 68

Healthcare IT Today

NOVEMBER 24, 2021

The companies are evolving in many ways, including stepping outside drug development to tryout digital treatments and using lessons from the COVID-19 pandemic to rethink production and clinical trials. Where are pharma companies investing their windfall profits?

Drug Development 132

Drug Development Pharmaceuticals Healthcare IT Health IT 132

Digital Health Global

JANUARY 9, 2024

The funding speaks to the global nature of pre-approval access and its increasing importance in the drug development process. “ Our mutual dedication to building new approaches to pharmaceutical drug development and patient care will help bring promising pre-approval medicine to patients around the world, faster and more equitably.

Pharmaceuticals 88

Pharmaceuticals Drug Development Digital Health Health Technology 88

Healthcare IT Today

JANUARY 7, 2025

As these implementations take hold, the emphasis will be on demonstrating measurable return on investment (ROI), with AI driving down administrative burdens, accelerating drug development, and significantly improving operational efficiency. What’s most exciting to me is AI’s potential impact on personalized medicine.

Health IT 93

Health IT Life Science Drug Development Pharmaceuticals 93

Healthcare IT Today

MARCH 15, 2024

We’re already seeing the benefits of AI-infused research in pharmaceuticals and drug development. According to WEF , the largest ten pharmaceutical companies have either partnered with or acquired AI companies to make use of AI-assisted drug development and design.

Pharmaceuticals 122

Pharmaceuticals Drug Development Mental health Nursing 122

Healthcare IT Today

JANUARY 8, 2024

It is key for pharmaceutical companies to recognize that efficiency does not override compliance, patient safety or regulatory standards. Jane Reed, Director of Life Sciences at Linguamatics, an IQVIA company Pharmaceutical developers have always prioritized drug safety. Dave Latshaw, CEO at BioPhy 1.

Health IT 93

Health IT Drug Development Pharmaceuticals BioTech 93

Lloyd Price

NOVEMBER 8, 2024

Several key trends and predictions are emerging: Increased focus on digital health and AI: AI-powered diagnostics and drug discovery: Companies specialising in AI-driven medical imaging, genomics analysis, and drug development are likely to attract significant interest from larger pharmaceutical and technology firms.

Digital Health 52

Digital Health healthcare technology Pharmaceuticals Telehealth 52

Society for Participatory Medicine

FEBRUARY 1, 2023

The FDA issued a series of four patient-focused drug development (PFDD) guidance documents which outline how patient co-design needs to successfully happen. By the power vested in clinical research, the FDA now pronounces us patient and industry. You may now kiss the cancer survivor.

BioTech 112

BioTech Drug Development Meaningful Use Pharmaceuticals 112

Insulin Nation

OCTOBER 16, 2015

One of the biggest pharmaceutical companies is placing a big bet that nasal glucagon is going to get FDA approval in the near future. has acquired the worldwide rights to a nasal glucagon product being developed by Locemia Solutions, according to a recent press release. Eli Lilly and Co.

Pharmaceuticals 97

Pharmaceuticals Drug Development 97

Lloyd Price

OCTOBER 14, 2024

Other Potential Topics: Pharmaceutical Industry: Trends in drug development, pricing, and access. Climate Change and Health: Examining the health implications of climate change and strategies for sustainable healthcare practices. Healthcare Financing: Investment trends, venture capital, and public-private partnerships.

Leadership 55

Leadership healthcare technology Digital Health Mental health 55

Digital Health Global

APRIL 5, 2024

DUBLIN–(BUSINESS WIRE)–The “Growth Opportunities in Drug Discovery and Early Development Outsourcing Services” report has been added to ResearchAndMarkets.com’s offering. hike over 2022, with more than 6,100 molecules in active development.

Drug Development 88

Drug Development Pharmaceuticals Digital Health Health Technology 88

Healthcare IT Today

NOVEMBER 7, 2023

This ML-driven adaptive process can significantly accelerate the clinical drug development process and increase certainty along the way, resulting in more efficient, targeted, and ultimately more successful clinical trials. Oramed Pharmaceuticals Inc.,

Drug Development 75

Drug Development BioTech Pharmaceuticals Health IT 75

Healthcare IT Today

OCTOBER 18, 2022

Redi.Health combines health management technology and pharmaceutical manufacturer support into one platform to enable patients to manage their complete health with a single interface. We understand how vital it is for outcomes and look forward to working with the Redi.Health team through its next phase of growth.”.

Pharmaceuticals 59

Pharmaceuticals Drug Development Health IT Healthcare IT 59

Digital Health Global

AUGUST 30, 2023

QuantHealth bridges these gaps by simulating trials at scale, to expedite, derisk, and optimize drug development. This decline is happening at a time when the need for efficient drug development has never been greater. This happens because there are major gaps in the research needed to support clinical trials.

BioTech 88

BioTech Drug Development Life Science Pharmaceuticals 88

Digital Health Global

AUGUST 22, 2024

Spellman and Wortel are the most recent additions to Catawba Research’s team of scientific and regulatory advisors who support sponsors across a multitude of therapeutic areas and provide clinical development and regulatory strategy across North America, Europe and Asia. After earning his M.D.

Leadership 88

Leadership Pharmaceuticals Drug Development Digital Health 88

Digital Health Global

SEPTEMBER 28, 2023

Investments will focus on the next generation of pharma R&D to accelerate drug development, on new technology solutions enabling a more patient-centric approach in clinical trials, and on digital platforms uncovering new insights from clinical data for more personalized care pathways.

Drug Development 88

Drug Development Pharmaceuticals Digital Health Life Science 88

Digital Health Global

NOVEMBER 2, 2023

Drug development The traditional drug discovery process is characterized by its protracted timeline, high costs, and significant attrition rates among drug candidates. There are three main advantages to the use of AI in drug development: width of research, speed of execution, low costs. DiMasi, H.G.

Drug Development 88

Drug Development Pharmaceuticals Public Health Telehealth 88

Lloyd Price

MAY 16, 2023

Palantir's products are also being used by pharmaceutical companies, medical device manufacturers, and healthcare payers. Precision medicine and genomics: Palantir has partnered with research institutions and pharmaceutical companies to support precision medicine initiatives. Palantir's plans for healthcare are ambitious.

Drug Development 90

Drug Development Health science Pharmaceuticals Public Health 90

Digital Health Global

JUNE 2, 2024

1 The collaboration between Massive Bio and Mika Health will also benefit the research both companies are performing with pharmaceutical companies and patient advocacy groups, by providing real-world data and insights into patient experiences and treatment outcomes.

Drug Development 88

Drug Development Pharmaceuticals Mental health Patient Experience 88

Digital Health Global

MARCH 26, 2024

Indivi is dedicated to unlocking the immense potential of digital biomarkers in drug development and healthcare by creating a unique symbiotic intersection between expert knowledge in Data Science, Clinical Science and Advanced Analytics (including machine learning and artificial intelligence).

Health Technology 88

Health Technology Digital Health BioTech Drug Development 88

Society for Participatory Medicine

JANUARY 27, 2022

Healthcare stakeholders such as health systems, pharmaceutical companies, biotech and life sciences firms, and insurance companies serve patients as end users. The same definition of patient engagement applies to industry, except that the interventions lead to more human centered design and value-based care.

BioTech 97

BioTech Life Science Drug Development Patient Experience 97

Digital Health Global

JUNE 20, 2023

million from Capital Grand Est and MACSF, as well as business angels, to accelerate its development in Europe and the United States. STRASBOURG, France–(BUSINESS WIRE)– BrainTale, a French medtech deciphering white matter to enable better brain care, announces it has gathered € 4.5 Today, the company has gathered €4.5

Life Science 88

Life Science Drug Development BioTech Pharmaceuticals 88

Digital Health Global

JANUARY 8, 2024

Top-10 global pharmaceutical companies are already benefiting from Medable’s novel technology, shaving weeks off build times. Medable’s new AI and automation capabilities catapult the company to the forefront of automating clinical trial operations and align with the industry’s perennial need to launch studies faster.

Life Science 88

Life Science Drug Development Pharmaceuticals HIPAA 88

Healthcare IT News - Telehealth

JANUARY 20, 2022

These allow pharmaceutical companies and contract research organizations to reach a more diverse patient pool and create a more accessible experience for patients as research no longer needs to be tied to specific trial sites. Decentralized clinical trials are already growing in popularity.

Life Science 203

Life Science Primary Care Mental health Drug Development 203

Society for Participatory Medicine

JANUARY 11, 2022

My thinking has evolved from the obvious, pharmaceutical companies strive to develop transformative therapies to change patients’ lives to a much stronger belief in the real meaning of patient centricity. These are great platitudes and mission statements, but how is patient centricity manifested in the real work that needs to be done?

Drug Development 81

Drug Development BioTech Patient Experience Pharmaceuticals 81

Healthcare IT Today

JULY 20, 2023

“Flywheel’s products transform healthcare innovation by empowering organizations to efficiently and securely ingest, curate and share medical imaging data for accelerated research and AI development,” said Flywheel CEO, Jim Olson.

Life Science 75

Life Science Drug Development Healthcare Innovation Pharmaceuticals 75

Digital Health Global

APRIL 16, 2024

The Phase IV trial, funded by a top-10 global pharmaceutical company, had a narrow recruitment window to enroll patients suffering from Anemia in End Stage Kidney Disease (ESKD) across more than 40 dialysis centers, involving 476 site users. .–(BUSINESS WIRE)– Medable Inc. , Renal Care ’s (USRC) investigator-initiated trial.

Drug Development 88

Drug Development Pharmaceuticals Health science Digital Health 88

Insulin Nation

OCTOBER 16, 2015

One of the biggest pharmaceutical companies is placing a big bet that nasal glucagon is going to get FDA approval in the near future. has acquired the worldwide rights to a nasal glucagon product being developed by Locemia Solutions, according to a recent press release. Eli Lilly and Co.

Pharmaceuticals 52

Pharmaceuticals Drug Development 52

Digital Health Global

SEPTEMBER 27, 2023

About Automera Automera is an early-stage company focused on the development of a novel therapeutic approach via autophagy-based targeted protein degradation. Automera’s AUTAC platform has broad potential across cancer and other disease areas, with oncology being the initial lead program.

Life Science 88

Life Science Drug Development HC BioTech 88

Insulin Nation

MARCH 24, 2019

The FDA declined to approve Zynquista a drug developed by Sanofi SA and Lexicon Pharmaceuticals intended for use with insulin in patients with Type 1 Diabetes. The generic name of the drug is sotagliflozin.

Drug Development 60

Drug Development Pharmaceuticals 60

Healthcare IT News - Telehealth

MAY 6, 2020

Biofourmis’ digital therapeutics are used for RPM across three primary healthcare stakeholder groups: health systems, payers and pharmaceutical companies. Typically, the health systems and payers work together in a value-based care arrangement that involves shared risk and reward.

Connected Health 217

Connected Health Telehealth Pharmaceuticals EHR 217